Page breadcrumb nav

VAERS Report 2156757

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fl9994


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-11
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

nausea; headache; fainting; very chilled; balance still poor; hit back of head on floor; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority. regulatory number: gb-mhra-webcovid-202202160938459070-2gvq9. other case identifier(s): gb-mhra-adr 26609350. a 67 year-old female patient received bnt162b2 (comirnaty), administration date 11feb2022 (lot number: fl9994) as dose 4 (booster), single for covid-19 immunisation. relevant medical history included: "lymphoma", start date: nov2019 (unspecified if ongoing); "chemotherapy", stop date: apr2021; "radiotherapy", stop date: apr2021; "neoplasm" (unspecified if ongoing), notes: recently had treatment for cancer, leukaemia or lymphoma (radiotherapy or chemotherapy); "spondylarthritis" (unspecified if ongoing); "blood pressure high" (unspecified if ongoing); "spondyloarthrosis" (unspecified if ongoing). patient has not had symptoms associated with covid-19. patient is not enrolled in clinical trial. concomitant medication(s) included: candesartan taken for hypertension, start date: 2018; etoricoxib taken for spondylitis, start date: 2012; leflunomide taken for spinal osteoarthritis, start date: 2012. past drug history included: rituximab, notes: 2 rituximab infusions november 21. vaccination history included: covid-19 vaccine (dose 3; manufacturer unknown), for covid-19 immunisation; covid-19 vaccine (dose 2; manufacturer unknown), for covid-19 immunisation; covid-19 vaccine (dose 1; manufacturer unknown), for covid-19 immunisation. the following information was reported: nausea (medically significant) with onset feb2022, outcome "not recovered", described as "nausea"; headache (medically significant) with onset feb2022, outcome "not recovered", described as "headache"; syncope (medically significant) with onset feb2022, outcome "recovering", described as "fainting"; chills (medically significant) with onset feb2022, outcome "unknown", described as "very chilled"; balance disorder (medically significant) with onset feb2022, outcome "unknown", described as "balance still poor"; head injury (medically significant) with onset feb2022, outcome "unknown", described as "hit back of head on floor". fainted 12 hours after vaccine. hit back of head on floor. very chilled for 5 hours. nausea, headache. improving after 4 days, but balance still poor. the patient underwent the following laboratory tests and procedures: lymphocyte count: about 0.56 currently; sars-cov-2 test: no - negative covid-19 test. patient has not tested positive for covid-19 since having the vaccine. no follow-up attempts are possible. no further information is expected

Données de laboratoire
test name: lymphocyte count; result unstructured data: test result:about 0.56 currently; test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test
Liste des symptômes
chills nausea headache balance disorder syncope head injury sars-cov-2 test lymphocyte count
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na